Skip Navigation

A Study of Enfortumab Vedotin ASG-22CE as Monotherapy or In Combination with Other Anticancer Therapies for the Treatment of Urothelial Cancer

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT03288545

Study #:
STUDY00141807

Start Date:
Feb 06, 2018

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03288545

View Complete Trial Details & Eligibility at ClinicalTrials.gov